SOLLINI, MARTINA
 Distribuzione geografica
Continente #
AS - Asia 2.704
EU - Europa 2.424
NA - Nord America 2.250
SA - Sud America 420
Continente sconosciuto - Info sul continente non disponibili 310
AF - Africa 82
OC - Oceania 26
Totale 8.216
Nazione #
US - Stati Uniti d'America 2.120
RU - Federazione Russa 1.182
SG - Singapore 989
CN - Cina 780
IT - Italia 729
BR - Brasile 351
HK - Hong Kong 309
BD - Bangladesh 213
VN - Vietnam 159
FR - Francia 98
DE - Germania 90
GB - Regno Unito 86
NL - Olanda 71
CA - Canada 67
IN - India 57
FI - Finlandia 53
MX - Messico 43
AR - Argentina 24
AU - Australia 24
JP - Giappone 24
PL - Polonia 24
MA - Marocco 23
AT - Austria 22
ZA - Sudafrica 22
TR - Turchia 18
PK - Pakistan 17
ES - Italia 16
TH - Thailandia 14
MY - Malesia 13
SA - Arabia Saudita 13
ID - Indonesia 12
LT - Lituania 11
CO - Colombia 10
DZ - Algeria 10
EG - Egitto 10
IQ - Iraq 10
SE - Svezia 10
AE - Emirati Arabi Uniti 9
EC - Ecuador 9
NP - Nepal 8
PH - Filippine 8
TW - Taiwan 8
VE - Venezuela 8
KR - Corea 7
UZ - Uzbekistan 7
PY - Paraguay 6
BE - Belgio 5
BO - Bolivia 5
JM - Giamaica 5
TN - Tunisia 5
UA - Ucraina 5
CL - Cile 4
CR - Costa Rica 4
IL - Israele 4
MD - Moldavia 4
BA - Bosnia-Erzegovina 3
IE - Irlanda 3
JO - Giordania 3
KE - Kenya 3
KZ - Kazakistan 3
NI - Nicaragua 3
OM - Oman 3
UY - Uruguay 3
ET - Etiopia 2
GA - Gabon 2
GE - Georgia 2
GT - Guatemala 2
LK - Sri Lanka 2
MM - Myanmar 2
PT - Portogallo 2
SC - Seychelles 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BY - Bielorussia 1
BZ - Belize 1
CM - Camerun 1
CU - Cuba 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EE - Estonia 1
HU - Ungheria 1
IR - Iran 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
LB - Libano 1
LU - Lussemburgo 1
PA - Panama 1
QA - Qatar 1
SN - Senegal 1
ST - Sao Tome e Principe 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TO - Tonga 1
TV - Tuvalu 1
Totale 7.906
Città #
Singapore 525
San Jose 326
Ashburn 313
Hong Kong 301
Moscow 260
Dallas 179
Milan 173
Beijing 156
Shanghai 141
Council Bluffs 126
New York 114
Hefei 105
Lauterbourg 81
Rome 74
Santa Clara 71
Los Angeles 69
Ho Chi Minh City 51
Hanoi 42
Seattle 32
Boardman 31
São Paulo 29
Helsinki 26
Naples 25
Nuremberg 23
Denver 22
Amsterdam 20
Brooklyn 20
Chennai 20
London 20
Montreal 20
Orem 20
Brescia 19
The Dalles 19
Washington 18
Mexico City 17
Turku 17
Warsaw 17
Bologna 16
Buffalo 16
Munich 16
Tokyo 16
Florence 15
Johannesburg 15
Omaha 15
Canberra 14
Toronto 14
Poplar 13
Atlanta 12
Cesano Boscone 12
Rio de Janeiro 12
Houston 11
Manchester 11
Shenzhen 11
Turin 11
Ankara 10
Bang Kruai 10
Figino 10
Lappeenranta 10
Las Vegas 10
Memphis 10
Mumbai 10
Phoenix 10
Chicago 9
Frankfurt am Main 9
Genoa 9
Guangzhou 9
Bari 8
Belo Horizonte 8
Da Nang 8
Charlotte 7
Curitiba 7
Falkenstein 7
Hangzhou 7
Rabat 7
San Francisco 7
Sydney 7
Vienna 7
Assago 6
Catania 6
City of London 6
Haiphong 6
Lahore 6
Oklahoma City 6
Pisa 6
Querétaro 6
Riyadh 6
Stockholm 6
Suzhou 6
Vancouver 6
Aracaju 5
Boston 5
Kuala Lumpur 5
Macerata 5
Philadelphia 5
Salvador 5
Secaucus 5
Tashkent 5
Augusta 4
Biên Hòa 4
Brasília 4
Totale 4.072
Nome #
Contrast-Enhanced Mammography versus Breast Magnetic Resonance Imaging: A Systematic Review and Meta-Analysis 313
Allogeneic Stem Cell Transplantation (Allo-SCT) after Treatment with Programmed Cell Death-1 (PD-1) Checkpoint Inhibitors for Relapsed/Refractory Classic Hodgkin Lymphoma (R/R cHL) Is Associated with an Unprecedented Low Relapse Rate 312
[F-18]FDG PET/CT in non-union: improving the diagnostic performances by using both PET and CT criteria 157
Complete remission of follicular lymphoma after SARS-CoV-2 infection: from the "flare phenomenon" to the "abscopal effect" 155
[18F]FDG-PET/CT Texture Analysis in “Hot” Thyroid Nodules: Results of the validation Cohort 151
Cardiac molecular pathways influenced by doxorubicin treatment in mice 139
Deep learning in Nuclear Medicine—focus on CNN-based approaches for PET/CT and PET/MR: where do we stand? 137
Match Point: Nuclear Medicine Imaging for Recurrent Thyroid Cancer in TENIS Syndrome—Systematic Review and Meta-Analysis 130
Time for action: actinium-225 PSMA-targeted alpha therapy for metastatic prostate cancer – a systematic review and meta-analysis 128
[18F]FDG PET/CT in Large Vessel Vasculitis: The Impact of Expertise and Confounders on Image Analysis 125
Challenging the significance of SUV-based parameters in a large-scale retrospective study on lung lesions 123
Cutting back on overdiagnosis – Occam’s Razor and unspecific bone uptakes in PSMA PET 120
Random forest analysis to predict Disease-Free Survival using FDG-PET and CT in Lung Cancer 117
Allogeneic transplantation after PD-1 blockade for classic Hodgkin lymphoma 117
[18F]FMCH PET/CT biomarkers and similarity analysis to refine the definition of oligometastatic prostate cancer 109
A virtual biopsy of liver parenchyma to predict the outcome of liver resection 107
Imaging-Based Prediction of Molecular Therapy Targets in NSCLC by Radiogenomics and AI Approaches: A Systematic Review 105
Ability of FDG PET and CT radiomics features to differentiate between primary and metastatic lung lesions 105
Climbing the steps of the evidence-based medicine pyramid: highlights from Annals of Nuclear Medicine 2019 105
Virtual Biopsy for Diagnosis of Chemotherapy-Associated Liver Injuries and Steatohepatitis: A Combined Radiomic and Clinical Model in Patients with Colorectal Liver Metastases 104
ALBI grade for outcome prediction in patients affected by hepatocellular carcinoma treated with transarterial radioembolization 101
Baseline circulating tumour DNA and interim PET predict response in relapsed/refractory classical Hodgkin lymphoma 101
Computed tomography based radiomic signature as predictive of survival and local control after stereotactic body radiation therapy in pancreatic carcinoma 100
Artificial intelligence and hybrid imaging: the best match for personalized medicine in oncology 97
Baseline Radiomic CT Features Differentiate Mediastinal Masses As Thymic Neoplasms Or Lymphomas 95
Computed tomography (CT)-derived radiomic features differentiate prevascular mediastinum masses as thymic neoplasms versus lymphomas 95
Chemotherapy-Associated Liver Injuries: Unmet Needs and New Insights for Surgical Oncologists 91
State-of-the-art of FAPI-PET imaging: a systematic review and meta-analysis 90
The five “W”s and “How” of Targeted Alpha Therapy: Why? Who? What? Where? When? and How? 89
Novel Radiopharmaceuticals and Future of Theranostics in Genitourinary Cancers 88
Baseline FDG-PET/CT Radiomics to Predict Outcome in Lung Cancer Patients Treated with Surgery 88
[18F]Fluorocholine PET/CT-guided stereotactic body radiotherapy in patients with recurrent oligometastatic prostate cancer 83
Towards clinical application of image mining: a systematic review on artificial intelligence and radiomics 79
PET/CT-based radiomics of mass-forming intrahepatic cholangiocarcinoma improves prediction of pathology data and survival 77
FAP expression in alpha cells of Langherhans insulae-implications for FAPI radiopharmaceuticals' use 77
Radiomics of Liver Metastases: A Systematic Review 77
The role of preoperative [11C]methionine PET in defining tumor-related epilepsy and predicting short-term postoperative seizure control in temporal lobe low-grade gliomas 77
Perceived risk and decision-making: navigating uncertainty in clinical practice 76
Application of Convolutional Neural Networks is promising in the definition of T-stage in lung cancer 75
Radiomics of Biliary Tumors: A Systematic Review of Current Evidence 74
The potential role of osteoporosis in unspecific [18F]PSMA-1007 bone uptake 74
On the Automation of Radiomics-based Identification and Characterization of NSCLC 73
Convolutional Neural Networks Promising in Lung Cancer T-Parameter Assessment on Baseline FDG-PET/CT 73
Alternative Nuclear Imaging Tools for Infection Imaging 72
Personalised PET imaging in oncology: an umbrella review of meta-analyses to guide the appropriate radiopharmaceutical choice and indication 71
The Role of PET Imaging in the Differential Diagnosis between Radiation Necrosis and Recurrent Disease in Irradiated Adult-Type Diffuse Gliomas: A Systematic Review 71
Radiomics and gene expression profile to characterise the disease and predict outcome in patients with lung cancer 71
Role of 11C Methionine Positron Emission Tomography (11CMETPET) for Surgery and Radiation Therapy Planning in Newly Diagnosed Glioblastoma Patients Enrolled into a Phase II Clinical Study 71
Hodgkin lymphoma and imaging in the era of anti-PD-1/PD-L1 therapy 69
What to Trust, PSA or [68Ga]Ga-PSMA-11: Learn from Experience 69
PSMA guided approach for bIoCHEmical relapse after prostatectomy- (PSICHE) trial (NCT05022914). Detection rate and treatment decision after 68Ga-PSMA PET/CT within a prospective study 69
Vasculitis changes in COVID-19 survivors with persistent symptoms: an [18F]FDG-PET/CT study 68
Radiomics of Intrahepatic Cholangiocarcinoma and Peritumoral Tissue Predicts Postoperative Survival: Development of a CT-Based Clinical-Radiomic Model 68
Methodological Aspects of Lymphoscintigraphy: Bicompartmental Versus Monocompartmental Radiocolloid Administration 68
The complementary role of PSMA expression and [18F]FDG PET/CT in predicting thyroid cancer outcome: from black and white to shades of gray, in the era of precision oncology 68
Long COVID hallmarks on [18F]FDG-PET/CT: a case-control study 67
Hybrid PET/MRI in Infection and Inflammation: An Update About the Latest Available Literature Evidence 67
Explainable domain transfer of distant supervised cancer subtyping model via imaging-based rules extraction 66
Prediction of disease-free survival by the PET/CT radiomic signature in non-small cell lung cancer patients undergoing surgery 65
Minimally-invasive treatments for benign thyroid nodules: a Delphi-based consensus statement from the Italian minimally-invasive treatments of the thyroid (MITT) group 63
State of the art of 18F-FDG PET/CT application in inflammation and infection: a guide for image acquisition and interpretation 61
Preoperative [11C]methionine PET to personalize treatment decisions in patients with lower-grade gliomas 61
Methodological framework for radiomics applications in Hodgkin’s lymphoma 59
Distributed learning: a reliable privacy-preserving strategy to change multicenter collaborations using AI 58
Value of FDG-PET/CT radiomic features in predicting response to anti-programmed death 1 (PD-1) antibodies treatment in refractory Hodgkin Lymphoma patients 58
PET/CT radiomics in breast cancer: Mind the step 58
Quantitative imaging biomarkers in nuclear medicine: from SUV to image mining studies. Highlights from annals of nuclear medicine 2018 58
From pixels to predictions: the scrying power of molecular imaging 57
PSMA expression level predicts differentiated thyroid cancer aggressiveness and patient outcome 57
Radiomic Analysis of Intrahepatic Cholangiocarcinoma: Non-Invasive Prediction of Pathology Data: A Multicenter Study to Develop a Clinical-Radiomic Model 57
Imaging Correlates between Headache and Breast Cancer: An [18F]FDG PET Study 57
Early biochemical outcomes following PSMA guided approach for bIoCHEmical relapse after prostatectomy-PSICHE trial (NCT05022914): preliminary results 56
Radioisotope-Guided Excision of Mediastinal Lymph Nodes in Patients with Non-Small Cell Lung Carcinoma: Feasibility and Clinical Impact 56
The Development of an Intelligent Agent to Detect and Non-Invasively Characterize Lung Lesions on CT Scans: Ready for the "Real World"? 56
Mapping Tumor Heterogeneity via Local Entropy Assessment: Making Biomarkers Visible 55
Recurrence-specific supervised graph clustering for subtyping Hodgkin Lymphoma radiomic phenotypes 55
Molecular imaging of IDH-mutant gliomas in the new era of IDH inhibitors: preparing for future challenges 55
PET/CT radiomics in breast cancer: promising tool for prediction of pathological response to neoadjuvant chemotherapy 55
Radiomics-Based Inter-Lesion Relation Network to Describe [18F]FMCH PET/CT Imaging Phenotypes in Prostate Cancer 54
Imaging-based representation and stratification of intra-tumor heterogeneity via tree-edit distance 54
The prognostic power of [11C]methionine PET in IDH-wildtype diffuse gliomas with lower-grade histological features: venturing beyond WHO classification 54
HCC Radioembolization with Yttrium-90 Polymer Beads (SIR-Spheres):Tc-99m-MAA SPECT/CT based dosimetry correlation with survival and tumor response 54
Radiomics signature as predictors of survival and local control after pancreatic carcinoma SBRT 54
Image Embeddings Extracted from CNNs Outperform Other Transfer Learning Approaches in Classification of Chest Radiographs 53
Contrast Administration Impacts CT-Based Radiomics of Colorectal Liver Metastases and Non-Tumoral Liver Parenchyma Revealing the "Radiological" Tumour Microenvironment 53
Texture analysis and machine learning to characterize suspected thyroid nodules and differentiated thyroid cancer: Where do we stand? 52
Patients' findings after COVID-19 infection and vaccinations: what to expect from [18F]FDG PET/CT 51
Things are because we see them (O. Wilde): new radiopharmaceuticals for nuclear medicine imaging 51
Interdisciplinarity: An essential requirement for translation of radiomics research into clinical practice -a systematic review focused on thoracic oncology 50
Present and future of target therapies and theranostics: refining traditions and exploring new frontiers-highlights from annals of Nuclear Medicine 2021 50
ED-B-Containing Isoform of Fibronectin in Tumor Microenvironment of Thymomas: A Target for a Theragnostic Approach 50
FDG PET/CT as theranostic imaging in diagnosis of non-small cell lung cancer 47
Dual adversarial deconfounding autoencoder for joint batch-effects removal from multi-center and multi-scanner radiomics data 47
COVID-19 vaccination, implications for PET/CT image interpretation and future perspectives 46
Role of Multimodal Imaging in Patients With Suspected Infections After the Bentall Procedure 46
Concerns About the Risk of Myeloid Malignancies After Radioiodine Therapy in Thyroid Cancer 45
Reply to: "Lack of evidence and criteria to evaluate artificial intelligence and radiomics tools to be implemented in clinical settings" 45
The Predictive Role of Radiomics in Breast Cancer Patients Imaged by [18F]FDG PET: Preliminary Results from a Prospective Cohort 43
Lymphoscintigraphy for the Differential Diagnosis of Peripheral Edema and Intracavitary Lymph Effusion 41
Molecular guidance for planning external beam radiation therapy in oncology 41
Totale 8.082
Categoria #
all - tutte 38.597
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.597


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/2023138 6 0 1 0 0 1 0 0 2 10 116 2
2023/2024717 8 145 82 45 56 69 33 85 41 35 31 87
2024/20251.548 157 53 21 59 80 143 177 158 305 194 114 87
2025/20265.106 382 352 198 620 449 168 620 322 1.122 296 248 329
2026/2027706 392 314 0 0 0 0 0 0 0 0 0 0
Totale 8.216